Skip to the page

Data / Form D filings / Karuna Pharmaceuticals Inc

Karuna Pharmaceuticals Inc: Form D filing

Karuna Pharmaceuticals Inc, a pharmaceuticals company in Boston, MA, filed a Form D with the SEC in 2011. The latest, on June 9, 2011, reports $600,000 sold of a $600,000 offering to 7 investors.

Find out what Karuna Pharmaceuticals Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
500 BOYLSTON STREET, SUITE 1600, Boston, MA, 02116
Phone
(617) 482-2333
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2009
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506
SEC identifier (CIK)
1522897

The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 9, 2011New notice$600,000$600,000$07May 25, 2011sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Stephen Marc MunizDirector
Daphne Marc ZoharDirector
Eric Marc ElenkoDirector
Edmund HarriganExecutive Officer, Director
Steven Marc PaulDirector

Other pharmaceuticals companies in Massachusetts that filed recently

Every Form D from the week of Jun 6, 2011 · All recent filings in Massachusetts · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what Karuna Pharmaceuticals Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.